| 1LL9 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | AXL | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1MXO, 1XX2 | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Using steric hindrance to design new inhibitors of class C beta-lactamases., Trehan I, Morandi F, Blaszczak LC, Shoichet BK, Chem Biol 2002 Sep;9(9):971-80. PMID:12323371 | ||||||||||||||
| Data retrieval |
![]() |
| View 1LL9 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |